Skip to content

Anthocyanin & Phenolic Acids Bioavailability & Antioxidant Capacity After Consumption of Purple Wheat Products in Adults

Bioavailability of Anthocyanins and Phenolic Acids and Changes in Blood Antioxidant Capacity After Consumption of Purple Wheat Anthocyanin-enriched Crackers and Granola Bars by Healthy Adult Participants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02730910
Enrollment
16
Registered
2016-04-07
Start date
2015-10-31
Completion date
2017-03-01
Last updated
2018-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Bioavailability, adults

Brief summary

This study will determine the bioavailability of anthocyanins and phenolic compounds from two purple wheat products, i.e. bran-enriched wholegrain purple wheat crackers and bran-enriched wholegrain purple wheat granola bars. Crackers are an example of a baked/ processed product. The purple wheat granola bars are an example of a food product that requires much less intensive preparation and cooking, compared to the crackers. A comparison of bioavailability between these two products should provide insights about how different processes and food matrix influence anthocyanin bioavailability and metabolism.

Detailed description

This study will determine the bioavailability of anthocyanins and phenolic compounds from two purple wheat products, i.e. bran-enriched wholegrain purple wheat crackers and bran-enriched wholegrain purple wheat granola bars. Crackers are an example of a baked/ processed product. The purple wheat granola bars are an example of a food product that requires much less intensive preparation and cooking, compared to the crackers. A comparison of bioavailability between these two products should provide insights about how different processes and food matrix influence anthocyanin bioavailability and metabolism. The study is a crossover investigation with 8 men and 8 women who will adhere to a low anthocyanin and low phenolic diet for the duration and complete 2 postprandial study visits where, in random order, they will consume either the crackers or granola bars. Blood and urine will be collected at baseline and postprandially for the analysis of anthocyanins and their metabolites and phenolic acids and determination of antioxidant capacity.

Interventions

OTHERPurple Wheat Crackers

Whole grain crackers manufactured with purple wheat

OTHERPurple Wheat Granola Bars

Whole grain granola bars manufactured with purple wheat

Sponsors

University of Guelph
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI of 18 - 27 kg/m2 * Generally healthy as determined by screening questionnaire * Non-smoking * Non to moderate alcohol drinkers (Typical consumption less than 5 drinks per sitting and no more than 14 per week)

Exclusion criteria

* Pregnant or breast-feeding females * History of any major disease or medical condition, including any disorder of the gastrointestinal system or food intolerances * Taking any prescription medications (including hormonal contraceptives) or over the counter medications prescribed by a medical professional * Taking any natural health products or dietary supplements, other than a multivitamin low in anthocyanins and phenolic acids * Oral antibiotic use in the past 3 months * Any food allergies, and any anaphylactic or life-threatening allergies - food or otherwise * Smokers or use of recreational drugs (marijuana, magic mushrooms, etc) * Elite or training athletes * Following a vegan or vegetarian diet

Design outcomes

Primary

MeasureTime frame
Plasma concentrations of anthocyanin metabolites0-8 hours (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8)

Secondary

MeasureTime frame
Plasma concentrations of phenolic acids0-8 hours (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8)
Plasma antioxidant capacity0-8 hours (0, 2, 4, 6, 8)
Urinary concentrations of phenolic acids0-8 hours (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8)
Urinary concentrations of anthocyanin metabolites0-8 hours (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026